EpiCeram: Clinical Trials

2 trials of EpiCeram, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting, 1 completed. 2 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 22Active not recruiting 1, Completed 1
Phase 11Completed 1

Follow EpiCeram: new trials by email Literature Review of EpiCeram trials Research Report on EpiCeram

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Seal, Stopping Eczema and Allergy Study
Tri-lipid skin barrier cream (Epiceram), Fluticasone propionate Cream 0.05%, Standard of Care - Eczema, Infantile, Eczema
Phase 2Active not recruitingKari Nadeau, MD, PhD3982021-06-302026-02-27
Wound Healing Endpoint and Recurrence
Epiceram Skin Barrier Function, Vaseline Petroleum Jelly - Chronic Wound, Burn Wound
Phase 1 / Phase 2CompletedSashwati Roy1062019-01-082026-11-18

Conditions studied

Bronchiolitis Obliterans Syndrome (1)  ·  Burns (1)  ·  Dermatitis (1)  ·  Dermatitis, Atopic (1)  ·  Diabetic Foot (1)  ·  Eczema (1)  ·  Food Hypersensitivity (1)  ·  Pressure Ulcer (1)  ·  Wounds and Injuries (1)

Sponsors

Kari Nadeau, MD, PhD (1)  ·  Sashwati Roy (1)

Countries

United States (2)  ·  United Kingdom (1)

Top investigators

Kari Nadeau, MD, PhD (1)  ·  Sashwati Roy, PhD (1)

Results publications

PMID 34398099

NIH funding

U01AI147462 (1)